Literature DB >> 30114540

Risk of Pseudoarthrosis After Spinal Fusion: Analysis From the Healthcare Cost and Utilization Project.

Ryan C Hofler1, Kevin Swong1, Brendan Martin2, Michael Wemhoff1, George Alexander Jones3.   

Abstract

BACKGROUND: Pseudoarthrosis after spinal fusion is an important cause of pain, neurologic decline, and reoperation.
METHODS: The Healthcare Cost and Utilization Project State Inpatient Databases were queried in New York, California, Florida, and Washington for adult patients who had undergone new spinal fusion from 2009 to 2011. In accordance with the Healthcare Cost and Utilization Project methods series and analysis guidelines, generalized linear mixed effects models were used to estimate the odds of experiencing postoperative pseudoarthrosis as a function of multivariable patient characteristics, comorbidities, and surgical approach.
RESULTS: Of the 107,420 patients who had undergone cervical fusion, 1295 (1.2%) developed pseudoarthrosis requiring reoperation. On multivariable analysis, the risk factors included posterior (odds ratio [OR], 4.47; 95% confidence interval [CI], 3.92-5.10) and combined (OR, 1.77; 95% CI, 1.33-2.36) approaches, fusion of ≥9 vertebrae (OR, 2.54; 95% CI, 1.38-4.68), smoking (OR, 1.19; 95% CI, 1.05-1.34), and long-term steroid use (OR, 1.89; 95% CI, 1.18-3.00). Of the 148,081 patients who underwent thoracic or lumbar fusion, 2665 (1.8%) developed pseudoarthrosis. Posterior (OR, 0.58; 95% CI, 0.51-0.56) and combined (OR, 0.46; 95% CI, 0.40-0.54) approaches resulted in reduced rates. Fusion of 4-8 vertebrae (OR, 1.52; 95% CI, 1.39-1.67), ≥9 vertebrae (OR, 1.87; 95% CI, 1.49-2.34), hypertension (OR, 1.18; 95% CI, 1.09-1.28), sleep apnea (OR, 1.48; 95% CI, 1.26-1.72), smoking (OR, 1.22; 95% CI, 1.12-1.33), and long-term steroid use (OR, 1.53, 95% CI, 1.08-2.18) resulted in increased rates.
CONCLUSIONS: These findings strongly associate several diagnoses with the development of pseudoarthrosis. However, further prospective studies are warranted to establish causation.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cervical fusion; Epidemiology; Healthcare Cost and Utilization Project; Large database; Long-term steroid use; Pseudoarthrosis; Reoperation; Spinal fusion; State Inpatient Database; Thoracolumbar fusion; Tobacco use

Mesh:

Substances:

Year:  2018        PMID: 30114540     DOI: 10.1016/j.wneu.2018.08.026

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  15 in total

1.  Implications of Drug Use Disorders on Spine Surgery.

Authors:  Christopher S Ferari; Gennadiy A Katsevman; Patricia Dekeseredy; Cara L Sedney
Journal:  World Neurosurg       Date:  2020-01-08       Impact factor: 2.104

Review 2.  Use of graft materials and biologics in spine deformity surgery: a state-of-the-art review.

Authors:  Ki-Eun Chang; Mohamed Kamal Mesregah; Zoe Fresquez; Eloise W Stanton; Zorica Buser; Jeffrey C Wang
Journal:  Spine Deform       Date:  2022-06-23

Review 3.  Successful fusion versus pseudarthrosis after spinal instrumentation: a comprehensive imaging review.

Authors:  John C Benson; Vance T Lehman; Arjun S Sebastian; Noelle A Larson; Ahmad Nassr; Felix E Diehn; John T Wald; Naveen S Murthy
Journal:  Neuroradiology       Date:  2022-06-14       Impact factor: 2.995

4.  Bidirectional Expandable Technology for Transforaminal or Posterior Lumbar Interbody Fusion: A Retrospective Analysis of Safety and Performance.

Authors:  Domagoj Coric; Raphael R Roybal; Mark Grubb; Vincent Rossi; Alex K Yu; Isaac R Swink; Jason Long; Boyle C Cheng; Jason A Inzana
Journal:  Int J Spine Surg       Date:  2020-10-29

5.  The use of demineralised bone fibres (DBF) in conjunction with supercritical carbon dioxide (SCCO2) treated allograft in anterior lumbar interbody fusion (ALIF).

Authors:  Jeremy Rajadurai; Vedran Lovric; Ralph J Mobbs; Wen Jie Choy; William R Walsh
Journal:  J Spine Surg       Date:  2019-12

6.  Risk Factors for Medical and Surgical Complications After Single-Level Minimally Invasive Transforaminal Lumbar Interbody Fusion.

Authors:  Ankur S Narain; James M Parrish; Nathaniel W Jenkins; Brittany E Haws; Benjamin Khechen; Kelly H Yom; Krishna T Kudaravalli; Jordan A Guntin; Kern Singh
Journal:  Int J Spine Surg       Date:  2020-04-30

Review 7.  Failures in Thoracic Spinal Fusions and Their Management.

Authors:  Marc Prablek; John McGinnis; Sebastian J Winocour; Edward M Reece; Udaya K Kakarla; Michael Raber; Alexander E Ropper; David S Xu
Journal:  Semin Plast Surg       Date:  2021-05-10       Impact factor: 2.314

Review 8.  Vascularized Rib Bone Grafting: Indications, Techniques, and Clinical Outcomes.

Authors:  Sebastian J Winocour; Nikhil Agrawal; Kathryn M Wagner; Matthew J Davis; Amjed Abu-Ghname; Rohil Shekher; Michael R Raber; Michael A Bohl; Alexander E Ropper; Edward M Reece
Journal:  Semin Plast Surg       Date:  2021-05-10       Impact factor: 2.314

9.  Efficacy and Safety of Balloon Kyphoplasty for Pathological Vertebral Fractures in Patients with Hematological Malignancies in Our Institution.

Authors:  Keigo Okada; Hiroki Fujiwara; Tomoyuki Arimatsu; Yotaro Motomura; Tsuyoshi Kato; Naoki Takezako; Takashi Kumagai
Journal:  Intern Med       Date:  2020-11-23       Impact factor: 1.271

10.  Should Implant Breakage Be Always Considered as Implant "Failure" in Spine Surgery: Analysis of Two Cases and Literature Review.

Authors:  Anuj Gupta; Kalidutta Das; Kuldeep Bansal; Harvinder Singh Chhabra; Mohit Arora
Journal:  Cureus       Date:  2021-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.